AQUIPTA 10 mg, Tabletten

7680691280016 CH-69128 Tabletten

Associated product:

AQUIPTA cpr 10 mg 28 pce
AQUIPTA 10 mg, Tabletten
AQUIPTA 10 mg, Tabletten
AQUIPTA 10 mg, Tabletten
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/07/2025
Patient information leaflet
Français
29/07/2025
Patient information leaflet
Italien
29/07/2025
Summary of Product Characteristics
Allemand
29/07/2025
Summary of Product Characteristics
Français
29/07/2025
Summary of Product Characteristics
Italien
29/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
5.26 MG Substance HBESI

Reimbursement information

Public price
CHF 421.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2024

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
69128
Drug name
AQUIPTA, Tabletten
Galenic form
TAB
ATC Code
N02CD07
Authorization status
Z
Dispensing category
B
First authorization
06/03/2024
Authorization expiration date
05/03/2029
IT Number
02.05.1.
Domain
Human medicine
Field of application
Migräneprophylaxe bei Erwachsenen

Package details

Description (FR)
AQUIPTA cpr 10 mg 28 pce
Description (DE)
AQUIPTA Tabl 10 mg 28 Stk
Market launch
06/03/2024
Narcotic (BTM)
No

Other package sizes (1)

AQUIPTA cpr 60 mg 28 pce
28 TABL
GTIN: 7680691280030
View